MorphoSys subsidiary, Pfizer sign technology transfer agreement
Sloning BioTechnology, a subsidiary of MorphoSys, and Pfizer have signed a non-exclusive license and technology transfer agreement.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Dec 10
Sloning BioTechnology, a subsidiary of MorphoSys, and Pfizer have signed a non-exclusive license and technology transfer agreement.
10 Dec 10
Stentys, a developer of stents to treat acute myocardial infarction (AMI), has begun the international Apposition III study…
10 Dec 10
Neoprobe, a developer of oncology surgical and diagnostic products, has requested and been granted a Type B pre-IND…
10 Dec 10
Covidien, a provider of mechanical ventilation and respiratory care devices, has made three new platforms for its Puritan…
10 Dec 10
Wolters Kluwer Health's unit Lippincott Williams & Wilkins has acquired iCare EMR, an educational electronic medical record (EMR)…
10 Dec 10
ArthroCare, a developer of minimally invasive surgical products, has receieved CE mark for its WoundWand Debridement Device (WoundWand)…
09 Dec 10
Prometheus Laboratories, a specialty pharmaceutical and diagnostic company, has entered into an oncology-focused mutational analysis services agreement with…
09 Dec 10
Caliper Life Sciences, a provider of products and services for drug discovery research, has entered into a definitive…
09 Dec 10
Ambry Genetics, a provider of genomic services focused on clinical diagnistics, has launched Illumina HiSeq 2000 next generation…
09 Dec 10
Ellipse Technologies has received CE mark approval for the Precice Limb Lengthening device, an intramedullary rod which provides…